Measurable residual disease assessment in apheresis product from multiple myeloma patients: association with biology, depth of response and survival.

Research Square 2026 Preprint Open access

Read full text
Authors: Noemí Puig, Borja Puertas, Irene Padilla, Elena Alejo, Fe Serra-Toral, Aránzazu García‐Mateo, R. López-López, Abelardo Bárez, José María Alonso, Carlos Aguilar-Franco, Erik de Cabo, Alberto Cantalapiedra-Diez
+13 more Alfonso García de Coca, R. Blanco Hernández, Beatriz Rey-Búa, Marta Fonseca Santos, Miriam López-Parra, Lucía López‐Corral, Norma Carmen Gutierrez, Maria-Belén Vidriales, Jose J Perez, Verónica González‐Calle, María‐Victoria Mateos, Fernando Escalante, Juan A Flores-Montero
DOI: 10.21203/rs.3.rs-8444748/v1
Cited by: 0
References: 32

Fields of Study & Subjects

Multiple Myeloma Research and Treatments Chronic Lymphocytic Leukemia Research Multiple Sclerosis Research Studies

Publication details

Journal / source
Research Square
Publication date
19 January 2026
Document type
Preprint